Back to Search
Start Over
Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Source :
-
PharmacoEconomics [Pharmacoeconomics] 2023 Nov; Vol. 41 (11), pp. 1551. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 1179-2027
- Volume :
- 41
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- PharmacoEconomics
- Accession number :
- 37665503
- Full Text :
- https://doi.org/10.1007/s40273-023-01315-1